Sigrid Klaar
Uppsala University(SE)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, HER2/EGFR in Cancer Research, Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies, Epigenetics and DNA Methylation
Most-Cited Works
- → An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival(2005)1,285 cited
- → Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts(2005)832 cited
- → The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.(2006)596 cited
- → Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients(2006)264 cited
- The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.(2001)
- → Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF(2005)57 cited
- Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort.(2001)
- → Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome(2007)40 cited
- → The European Medicines Agency Review of Eribulin for the Treatment of Patients with Locally Advanced or Metastatic Breast Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use(2012)39 cited
- → A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in Sweden(2002)22 cited